{"id":"W3129342924","doi":"10.2217/cer-2020-0272","title":"Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Palbociclib; Hazard ratio; Oncology; Internal medicine; Breast cancer; Hormone receptor; Gynecology; Cancer; Confidence interval; Metastatic breast cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01447957,0.001071862,0.001949784,0.0007626117,0.0002258023,0.0009387299,0.0009578688,0.000874879,0.006858809],"category_scores_gemma":[0.02503992,0.0003800006,0.006498226,0.0007079121,0.0005520539,0.0008093753,0.001273019,0.001623449,0.0004039064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001034045,"about_ca_system_score_gemma":0.0009302376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001477643,"about_ca_topic_score_gemma":0.001651788,"domain_scores_codex":[0.976497,0.01963158,0.001200384,0.001015987,0.001124969,0.0005300558],"domain_scores_gemma":[0.9911377,0.005667256,0.001818658,0.0008686328,0.0003029727,0.0002048624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6852097,0.002511069,0.03711687,0.004932427,0.1159665,0.00011696,0.0003071907,0.01522349,0.002658411,0.00346179,0.002062293,0.1304333],"study_design_scores_gemma":[0.2747269,0.232332,0.201565,0.001452934,0.2026106,0.0007058568,0.0005494102,0.04146341,0.01268558,0.01443693,0.01717614,0.0002950996],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961701,0.01184565,0.01257244,0.0005246131,0.0006044747,0.003063766,0.003705099,0.0001262915,0.005856628],"genre_scores_gemma":[0.9926578,0.0006586554,0.003598773,0.0002341095,0.0000659481,0.001125592,0.0008747504,0.0000116611,0.0007726985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01447957,"threshold_uncertainty_score":0.07657617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09824933317196574,"score_gpt":0.4667089789174239,"score_spread":0.3684596457454581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}